Sagimet Biosciences Inc. (SGMT) Financials

SGMT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 107.8 million 5.3 million
Dec. 31, 2025 116.5 million 5.1 million
Sept. 30, 2025 128.4 million 9.1 million
June 30, 2025 137.4 million 7.2 million

SGMT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -8.6 million 1.8 million
Dec. 31, 2025 -11.8 million 1.7 million
Sept. 30, 2025 -10.2 million 1.7 million
June 30, 2025 -9.1 million 1.6 million

SGMT Net Income

No data available :(

SGMT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 104.5 million - 39000
Dec. 31, 2025 113.1 million - 78000
Sept. 30, 2025 116.7 million - 115000
June 30, 2025 125.4 million - 152000

SGMT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 32.6 million
Dec. 31, 2025 32.3 million
Sept. 30, 2025 32.5 million
June 30, 2025 32.2 million

SGMT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 7.0 million 4.7 million -
Dec. 31, 2025 - 6.7 million 4.0 million -
Sept. 30, 2025 - 9.7 million 4.6 million -
June 30, 2025 - 7.2 million 4.7 million -

SGMT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - -

SGMT

Price: $6.27

52 week price:
3.83
11.41

Earnings Per Share: -1.35 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 223.5 million

Links: